News & Analysis on Clinical Trial Services & Contract Research And Development
Dr. James Pursey
By Dan Stanton
- Last updated on
Next up is news from the WuXiPRA Chinese joint venture, who has named Dr. James Pursey as President and General Manager, as reported this week in this publication.
“Under James's leadership, we believe WuXiPRA will become the clinical CRO of choice in China," said Dr. Ge Li, Chairman and CEO of WuXi PharmaTech.
"WuXi PharmaTech's local expertise and PRA's leading-edge global systems and processes will enable customers to conduct the highest-quality clinical trials in China quickly and successfully for Chinese and international regulatory filings.”